Research Evidence Comparison# Retatrutide Research# Phase 1 : First-in-human study established safety and pharmacokinetics Phase 2 (n=338) : Published in NEJM (2023), demonstrated dose-dependent weight loss up to 24.2% at 48 weeks with 12 mg dose
Compared with db/db mice, the Low and High groups treated with berberine had lower blood glucose levels after intraperitoneal injection of glucose and insulin (Figures 1E, G)
Some need slow increases, while others respond faster
A key component of this protocol is Protein A/G agarose beads that bind the constant domain of antibodies- allowing immunoprecipitation of the target protein
Eklof V, Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Palmqvist R
In order to assess communication, USVs were recorded during male-female interaction pairings